Abstract:Background and Aim: Tumor necrosis factor receptor superfamily member 6b (TNFRSF6B), also identified as DcR3, has been stated to play a crucial role in the tumorigenesis and progression of several cancers. However, the biological function and clinical role of DcR3 in breast cancer (BRCA) has not been fully clarified. Hence, the aim of the study was to explore the impact of DcR3 on biological function of BRCA cells with in vitro experiments, as well as to assess the clinical significance of DcR3 bases on a meta-analysis and public data. Material and Methods: DcR3 neutralization antibody and DcR3-siRNA were transfected into BRCA MCF-7 cells. Three approaches including MTS assay, viability assay and Hoechst 33342/propidium iodide (PI) double staining assay were employed to examine the cell growth. Furthermore, the apoptosis was monitored by fluorescent caspase-3/7 assay and the Hoechst 33342/PI assay. Information of the association of DcR3 expression and some clinicopathological parameters including tumor differentiation, lymph node metastasis, clinical TNM stage, etc. were extracted in BRCA related literature, and pooled odds ratios (ORs) and 95% confidence intervals (CIs) were evaluated by Forest plot in the current meta-analysis. Furthermore, data mining was performed in The Cancer Genome Atlas (TCGA) public database to verify the clinical significance of DcR3 in BRCA. Results: Both DcR3 neutralization antibody and siRNA showed obvious cell growth suppression effect on BRCA MCF-7 cells as detected by three methods. Consistently, DcR3 neutralization antibody and siRNA also yielded remarkable impact on inducing caspase-3/7 activity and apoptosis. DcR3-siRNA led to a much more potent influence on biological function than DcR3 neutralization antibody in BRCA cells. In the meta-analysis, over-expression of DcR3 was strongly interrelated with the occurrence of BRCA, also differentiation, lymph node metastasis and TNM stage. Moreover, 9% genetic alteration was noted based on TCGA database in 1105 BRCA samples. Conclusions: The present discoveries propose that the over-expression of DcR3 might be associated with the malignant aggressiveness and progression of BRCA, via influencing cell growth and apoptosis. DcR3 may become a probable notable target for the molecular therapy of BRCA. But the specific pathway and precise molecular mechanisms of DcR3 in BRCA cells remain to be further explored.

Expression of death receptor-3 in human breast cancer and its functional effects on breast cancer cells in vitro.

Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.

Aberrant Expression and Function of Death Receptor-3 and Death Decoy Receptor-3 in Human Cancer.

Role of REIC/Dkk-3 Protein in Tumorigenesis

Effects of the Knockdown of Death-Associated Protein 3 Expression on Cell Adhesion, Growth and Migration in Breast Cancer Cells.

Decoy Receptor 3 (dcr3) As a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.

Expression and Clinicopathological Implication of DcR3 in Lung Cancer Tissues: a Tissue Microarray Study with 365 Cases.

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3 IN HUMAN BREAST CANCER AND ITS SIGNIFICANCE

Investigation of Targeting Relationship Between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcinoma

Impact of TNFRSF 6 B / DcR 3 neutralization antibody and SiRNA on biological function of MCF-7 breast cancer cells

Death-associated Protein-3, DAP-3, Correlates with Preoperative Chemotherapy Effectiveness and Prognosis of Gastric Cancer Patients Following Perioperative Chemotherapy and Radical Gastrectomy.

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer

Function of RasGRP3 in the formation and progression of human breast cancer

Intratumoral Expression Of Ccr3 In Breast Cancer Is Associated With Improved Relapse-Free Survival In Luminal-Like Disease

Death Receptor 3 is Involved in Preeclampsia Through Regulating Placental Trophoblast Cell Physiology by Inactivating the PI3K/AKT Pathway.

Death-associated protein 3 in cancer—discrepant roles of DAP3 in tumours and molecular mechanisms

Death Receptor 5 Promotes Tumor Progression in Gastric Cancer.

GDF3 Inhibits the Growth of Breast Cancer Cells and Promotes the Apoptosis Induced by Taxol

DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer

Ndrg3 Is An Androgen Regulated And Prostate Enriched Gene That Promotes In Vitro And In Vivo Prostate Cancer Cell Growth

Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.